Barclays »

Keros Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 99k 15.82
2025-06-30 $1.6M 121k 13.36
2025-03-31 $611k 60k 10.20
2024-12-31 $1.7M 108k 15.84
2024-09-30 $3.5M 60k 58.06
2024-06-30 $1.1M 25k 45.64
2024-03-31 $4.6M 70k 66.19
2023-12-31 $10M 260k 39.76
2023-09-30 $1.6M 50k 31.87
2023-06-30 $1.5M 38k 40.16
2023-03-31 $1.3M 29k 42.70
2022-12-31 $1.8M 38k 48.03
2022-09-30 $3.7M 98k 37.62
2022-06-30 $936k 34k 27.60
2022-03-31 $691k 13k 54.36